• US Preventive Services Task Force, Michael J Barry, Wanda K Nicholson, Michael Silverstein, Michael D Cabana, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén, Li Li, Gbenga Ogedegbe, Goutham Rao, John M Ruiz, James Stevermer, Joel Tsevat, Sandra Millon Underwood, and John B Wong.
• Harvard Medical School, Boston, Massachusetts.
• JAMA. 2023 Sep 19; 330 (11): 107410821074-1082.

ImportanceHypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017.ObjectiveThe US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy.PopulationPregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension.Evidence AssessmentThe USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit.RecommendationThe USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

10 keywords...

hide…